Foresight VCT PLC
04 April 2007
Foresight VCT plc
Allotment of Ordinary Shares and Closure of Offer
The Board is pleased to announce that in accordance with the terms of the Offer
for Subscription dated 20 March 2007 (the 'Offer'), 1,741,849 Ordinary Shares of
1 pence each were allotted on 4 April 2007 at 83.00 pence per share.
Application has been made for the admission of the 1,741,849 Ordinary Shares to
the Official List of the UK Listing Authority and to trading on London Stock
Exchange plc's market for listed securities.
Total shares allotted to date under the Offer by the Company are 1,741,849
ordinary shares. Following this allotment there are now 46,940,632 Ordinary
Shares of 1p each in issue.
This allotment, when aggregated with existing applications still to be allotted
has resulted in the Company achieving its maximum allowable Offer proceeds. The
Offer for Subscription is therefore closed to all new applications.
For further information please contact:
Gary Fraser, Foresight Venture Partners: 01732 471 800
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.